APUS stock news · Apimeds Pharmaceuticals US, Inc.
Get alerts for APUS
Follow Apimeds Pharmaceuticals US, Inc. (APUS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for APUSApimeds Pharmaceuticals US, Inc.: Other Events (APUS)
Good for APUSApimeds' subsidiary signed a two-year insurance technology deal. It adds a paid project, but service fees and much of the token-based payment remain uncertain, so the news leans positive.
Here are 12 health care stocks that changed a lot during Friday's trading.
NeutralApimeds Pharmaceuticals shares fell 17% during Friday's session. The report gives no company news behind the move, so it does not change what we know about the business.
Here are 12 health care stocks that changed a lot during Wednesday's trading.
NeutralApimeds Pharmaceuticals shares rose about 21% to $8.60 per share. The story gives no company update, so this move alone does not change what we know about its business.
12 health care companies saw big price changes during Tuesday's trading.
NeutralApimeds Pharmaceuticals shares rose about 53% during Tuesday's session, but this article gives no company news explaining the move. It does not change the company's business outlook.
12 health care stocks are changing a lot during Monday's trading.
NeutralApimeds Pharmaceuticals shares rose 36.64% during Monday’s session, but the story gives no reason or company update. The price move alone does not change its business outlook.
12 health care companies saw big changes during Monday's trading.
NeutralApimeds Pharmaceuticals' shares rose 37% on Monday. The story gives no company news to show that its business prospects changed.
Apimeds Pharmaceuticals stock is going up today because its partner is working on a new blockchain project.
Good for APUSApimeds' subsidiary signed a two-year blockchain services deal that includes development fees. Unset future fees and work conditions limit the promise, but the signed paid work supports a positive read.
Apimeds Pharmaceuticals stock is going up today because its partner is working on a new blockchain project.
Good for APUSApimeds' subsidiary signed a two-year insurance and reinsurance blockchain deal. Scheduled development fees and an exclusive role support the company's business outlook, though later fees and token benefits remain uncertain.
12 health care companies are changing in price before the market opens on Monday.
NeutralApimeds Pharmaceuticals shares climbed before Monday's open, but the story reports no company news behind the move. It does not change the picture of APUS's business.
Apimeds Pharmaceuticals US, Inc. says its CFO stepped down and a new one was hired.
NeutralAPUS's finance chief resigned, and an experienced CFO is set to take over. No dispute was reported, so this looks like a handoff, not a change in business outlook.
Apimeds Pharmaceuticals says its subsidiary MindWave Innovations made two big deals with AQUAE Holdings.
Good for APUSAPUS subsidiary MindWave signed two 12-month technology-service deals, bringing fees and digital assets. The work supports APUS, though its value depends on delivery and assets whose prices are not stated.
12 health care stocks are changing a lot before the market opens on Monday.
NeutralThe report says Apimeds shares fell 15.04% to $6.16 before trading. It gives no company news explaining the move, so the story does not change the company's outlook.
Here are 12 health care stocks that changed a lot during Friday's trading.
NeutralApimeds Pharmaceuticals shares rose 33.13% during Friday's session, but the article gives no company news or reason for the rise. It does not change the outlook for Apimeds.
On Thursday, 12 health care stocks changed a lot during the day.
NeutralApimeds shares jumped intraday to about $6, but the item only reports a price spike with no company news, so our view of Apimeds is unchanged.
Crude oil prices go up more than 4%, while Darden's earnings fall short of what people expected.
Good for APUSApimeds shares jumped after its subsidiary signed a 12-month tech services deal to deploy MindChain infrastructure.
On Friday evening, 12 health care stocks saw big changes in their prices.
NeutralApimeds Pharmaceuticals shares rose 6.77% to $1.89 after-market. The article gives only price moves, so it does not change Apimeds' prospects.
Apimeds Pharmaceuticals US, Inc. has signed an important agreement and added a new director, Sungjoon Chae.
NeutralApimeds amended a settlement to change board makeup and added Sungjoon Chae; I read this as a governance change that does not change the company's prospects.
Apimeds Pharmaceuticals US, Inc. announces the establishment of a significant definitive agreement (APUS).
Good for APUSApimeds Pharmaceuticals US, Inc. has filed a Form 8-K indicating the entry into a material definitive agreement, which is likely to have a positive impact on its strategic direction and financial outlook.